Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study.
Antibody-based methods for the measurement of α-synuclein concentration in human cerebrospinal fluid - method comparison and round robin study.
复制标题
DOI:
10.1111/jnc.14569
复制
发表时间:
2019-04
影响因子:
4.7
通讯作者:
Zetterberg H
中科院分区:
文献类型:
--
作者:
Mollenhauer B;Bowman FD;Drake D;Duong J;Blennow K;El-Agnaf O;Shaw LM;Masucci J;Taylor P;Umek RM;Dunty JM;Smith CL;Stoops E;Vanderstichele H;Schmid AW;Moniatte M;Zhang J;Kruse N;Lashuel HA;Teunissen C;Schubert T;Dave KD;Hutten SJ;Zetterberg H
α‐Synuclein is the major component of Lewy bodies and a candidate biomarker for neurodegenerative diseases in which Lewy bodies are common, including Parkinson's disease and dementia with Lewy bodies. A large body of literature suggests that these disorders are characterized by reduced concentrations of α‐synuclein in cerebrospinal fluid (CSF), with overlapping concentrations compared to healthy controls and variability across studies. Several reasons can account for this variability, including technical ones, such as inter‐assay and inter‐laboratory variation (reproducibility). We compared four immunochemical methods for the quantification of α‐synuclein concentration in 50 unique CSF samples. All methods were designed to capture most of the existing α‐synuclein forms in CSF (‘total’ α‐synuclein). Each of the four methods showed high analytical precision, excellent correlation between laboratories (R 2 0.83–0.99), and good correlation with each other (R 2 0.64–0.93), although the slopes of the regression lines were different between the four immunoassays. The use of common reference CSF samples decreased the differences in α‐synuclein concentration between detection methods and technologies. Pilot data on an immunoprecipitation mass spectrometry (IP‐MS) method is also presented. Our results suggest that the four immunochemical methods and the IP‐MS method measure similar forms of α‐synuclein and that a common reference material would allow harmonization of results between immunoassays.
登录
查看更多内容
影响因子:
5.3
作者:
Janelidze S;Zetterberg H;Mattsson N;Palmqvist S;Vanderstichele H;Lindberg O;van Westen D;Stomrud E;Minthon L;Blennow K;Swedish BioFINDER study group;Hansson O
通讯作者:
Hansson O
影响因子:
3.7
作者:
Kapaki E;Paraskevas GP;Emmanouilidou E;Vekrellis K
通讯作者:
Vekrellis K
影响因子:
7.1
作者:
Groveman BR;Orrù CD;Hughson AG;Raymond LD;Zanusso G;Ghetti B;Campbell KJ;Safar J;Galasko D;Caughey B
通讯作者:
Caughey B
影响因子:
14
作者:
Llorens, Franc;Kruse, Niels;Zerr, Inga
通讯作者:
Zerr, Inga
影响因子:
14.5
作者:
Hong, Zhen;Shi, Min;Zhang, Jing
通讯作者:
Zhang, Jing